ED, Evidence Generation TA Head - Oncology
Novartis
3 months ago
Remote
United States
$225,400 - $418,600 USD yearly
Clinical Research and Development
Executive Director, Evidence Generation TA Head - Oncology
Role Responsibilities
- Lead an Evidence Generation (EG) team supporting Oncology, driving evidence generation and communication plans for priority pipeline and marketed assets in the US.
- Lead a team of researchers executing scientifically robust research, including real-world/HEOR studies, economic modeling, patient preference studies, and non-interventional studies.
- Ensure the US EG team portfolio is reflected in integrated evidence plans.
- Lead/co-lead development and implementation of Research Collaborations (RCs) for population health initiatives.
- Ensure strategic alignment for US access-related Medical efforts in collaboration with VEL, Market Access, Medical Directors, and other internal partners.
- Drive cross-functional value-evidence strategies, evidence generation, and evidence communication plans throughout the product lifecycle with measurable impact.
- Collaborate/lead payer strategy and interactions, including development of evidence plans and submissions, and maintain expertise on payer, regulatory, and policy trends affecting access and reimbursement.
- Provide external thought leadership via partnerships with scientific leaders and participation/presentations and exchanges with payers and health systems (e.g., FDA, CMS).
- Partner with internal stakeholders on research strategies, tactics, and outcomes aligned to business and medical/commercial/access goals.
- Lead people and culture: attract and develop talent; coach and provide feedback; build culture.
- Deliver operational excellence through account/system-based plans with tracking of business impact.
- Lead EG TA business planning and manage the assigned external budget and operating expenses to optimize investment impact.
Essential/Required Qualifications
- Master’s or higher degree in Health Economics, Public Health, Epidemiology, Health Services Research, or related field.
- Minimum 8 years of progressively senior experience in Health Economics, Outcomes Research, and/or Market Access in biotech/pharma/healthcare.
- Minimum 3 years people management experience; proven track record leading large teams (experience with field-based medical org preferred).
- Deep knowledge of the US payer environment, trends, and competitive landscape.
- Expert knowledge across a broad range of research methodologies.
- Ability to develop and deliver communications for external US audiences.
- Experience designing clinical studies with patient-centered, clinical, and economic endpoints.
- Ability to develop, validate, and/or use Patient Reported Outcomes (PRO) measures.
- Experience analyzing US claims and/or HER databases for burden/cost and/or real-world outcomes.
- Demonstrated experience developing economic and/or disease models to assess value and predict economic/budget impact.
- Ability to prioritize, delegate, and build talent through guidance/mentorship.
- Ability to develop strategic vision and transition strategy to implementation with tracked metrics and strong initiative.
Preferred Qualifications
- PhD, MD, or PharmD with focus in Health Economics, Public Health, Epidemiology, Health Services Research, or related field.
Required/Role Practical Details
- Remote in the US (legal entity restrictions may apply); no relocation.
- 25% travel required.
Compensation/Benefits (as stated)
- Salary expected range: $225,400–$418,600 per year.
- Performance-based cash incentive; eligibility for annual equity awards depending on level.
- Comprehensive benefits including health, life, disability, 401(k) with company contribution and match, and other benefits; generous time off (vacation, personal days, holidays, and other leaves).
Role Responsibilities
- Lead an Evidence Generation (EG) team supporting Oncology, driving evidence generation and communication plans for priority pipeline and marketed assets in the US.
- Lead a team of researchers executing scientifically robust research, including real-world/HEOR studies, economic modeling, patient preference studies, and non-interventional studies.
- Ensure the US EG team portfolio is reflected in integrated evidence plans.
- Lead/co-lead development and implementation of Research Collaborations (RCs) for population health initiatives.
- Ensure strategic alignment for US access-related Medical efforts in collaboration with VEL, Market Access, Medical Directors, and other internal partners.
- Drive cross-functional value-evidence strategies, evidence generation, and evidence communication plans throughout the product lifecycle with measurable impact.
- Collaborate/lead payer strategy and interactions, including development of evidence plans and submissions, and maintain expertise on payer, regulatory, and policy trends affecting access and reimbursement.
- Provide external thought leadership via partnerships with scientific leaders and participation/presentations and exchanges with payers and health systems (e.g., FDA, CMS).
- Partner with internal stakeholders on research strategies, tactics, and outcomes aligned to business and medical/commercial/access goals.
- Lead people and culture: attract and develop talent; coach and provide feedback; build culture.
- Deliver operational excellence through account/system-based plans with tracking of business impact.
- Lead EG TA business planning and manage the assigned external budget and operating expenses to optimize investment impact.
Essential/Required Qualifications
- Master’s or higher degree in Health Economics, Public Health, Epidemiology, Health Services Research, or related field.
- Minimum 8 years of progressively senior experience in Health Economics, Outcomes Research, and/or Market Access in biotech/pharma/healthcare.
- Minimum 3 years people management experience; proven track record leading large teams (experience with field-based medical org preferred).
- Deep knowledge of the US payer environment, trends, and competitive landscape.
- Expert knowledge across a broad range of research methodologies.
- Ability to develop and deliver communications for external US audiences.
- Experience designing clinical studies with patient-centered, clinical, and economic endpoints.
- Ability to develop, validate, and/or use Patient Reported Outcomes (PRO) measures.
- Experience analyzing US claims and/or HER databases for burden/cost and/or real-world outcomes.
- Demonstrated experience developing economic and/or disease models to assess value and predict economic/budget impact.
- Ability to prioritize, delegate, and build talent through guidance/mentorship.
- Ability to develop strategic vision and transition strategy to implementation with tracked metrics and strong initiative.
Preferred Qualifications
- PhD, MD, or PharmD with focus in Health Economics, Public Health, Epidemiology, Health Services Research, or related field.
Required/Role Practical Details
- Remote in the US (legal entity restrictions may apply); no relocation.
- 25% travel required.
Compensation/Benefits (as stated)
- Salary expected range: $225,400–$418,600 per year.
- Performance-based cash incentive; eligibility for annual equity awards depending on level.
- Comprehensive benefits including health, life, disability, 401(k) with company contribution and match, and other benefits; generous time off (vacation, personal days, holidays, and other leaves).